TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs3130501
log Bayes Factor = 56.6483
Chromosome 6   position 31,136,453  (GRCh37) Explore rs3130501 on Ensembl!
Variant rs3130501 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
E03.9 Hypothyroidism, unspecified
0.000 0.000 1.000
K90.0 Coeliac disease
0.000 0.000 1.000
E10-E14 Diabetes mellitus
0.000 0.000 1.000
E10.9 Without complications
0.000 0.000 1.000
E00-E07 Disorders of thyroid gland
0.000 0.000 1.000
E03 Other hypothyroidism
0.000 0.000 1.000
L40.9 Psoriasis, unspecified
0.000 0.000 1.000
E10 Insulin-dependent diabetes mellitus
0.000 0.000 1.000
Chapter IV Endocrine, nutritional and metabolic diseases
0.000 0.000 1.000
E83.1 Disorders of iron metabolism
0.999 0.001 0.000
E11.9 Without complications
0.000 0.001 0.999
E11 Non-insulin-dependent diabetes mellitus
0.000 0.001 0.999
E05.9 Thyrotoxicosis, unspecified
0.000 0.004 0.996
E05 Thyrotoxicosis [hyperthyroidism]
0.000 0.004 0.996
E78.0 Pure hypercholesterolaemia
0.000 0.014 0.986
E78 Disorders of lipoprotein metabolism and other lipidaemias
0.000 0.017 0.983
E70-E90 Metabolic disorders
0.000 0.022 0.978
G35 Multiple sclerosis
0.976 0.024 0.000
L40 Psoriasis
0.000 0.046 0.954
E14 Unspecified diabetes mellitus
0.000 0.086 0.914
L40.5 Arthropathic psoriasis
0.000 0.112 0.888
E11.0 With coma
0.000 0.122 0.878
E78.8 Other disorders of lipoprotein metabolism
0.000 0.134 0.866
E07 Other disorders of thyroid
0.000 0.158 0.842
E03.2 Hypothyroidism due to medicaments and other exogenous substances
0.000 0.164 0.836
E10.3 With ophthalmic complications
0.000 0.185 0.815
E78.2 Mixed hyperlipidaemia
0.000 0.187 0.813
E80 Disorders of porphyrin and bilirubin metabolism
0.000 0.192 0.808
L40.0 Psoriasis vulgaris
0.000 0.195 0.805
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.000 0.201 0.799
E14.3 With ophthalmic complications
0.000 0.202 0.798
L40.8 Other psoriasis
0.000 0.202 0.798
E03.8 Other specified hypothyroidism
0.000 0.209 0.791
E11.1 With ketoacidosis
0.000 0.212 0.788
E79 Disorders of purine and pyrimidine metabolism
0.000 0.235 0.764
E78.4 Other hyperlipidaemia
0.000 0.243 0.757
E10.6 With other specified complications
0.000 0.247 0.753
E10.8 With unspecified complications
0.000 0.251 0.749
E74 Other disorders of carbohydrate metabolism
0.000 0.251 0.749
E14.9 Without complications
0.000 0.253 0.747
K90 Intestinal malabsorption
0.000 0.254 0.746
E78.1 Pure hyperglyceridaemia
0.000 0.258 0.742
E07.9 Disorder of thyroid, unspecified
0.000 0.259 0.741
L40.1 Generalised pustular psoriasis
0.000 0.272 0.728
E11.2 With renal complications
0.000 0.276 0.724
E13 Other specified diabetes mellitus
0.000 0.279 0.721
E14.5 With peripheral circulatory complications
0.000 0.280 0.720
G35-G37 Demyelinating diseases of the central nervous system
0.718 0.282 0.000
E12 Malnutrition-related diabetes mellitus
0.000 0.283 0.717
E01 Iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.283 0.717
E00 Congenital iodine-deficiency syndrome
0.000 0.283 0.717
E03.5 Myxoedema coma
0.000 0.283 0.717
E03.4 Atrophy of thyroid (acquired)
0.000 0.283 0.717
E03.3 Postinfectious hypothyroidism
0.000 0.283 0.717
E03.0 Congenital hypothyroidism with diffuse goitre
0.000 0.283 0.717
E10.7 With multiple complications
0.000 0.283 0.717
E11.7 With multiple complications
0.000 0.284 0.716
E05.5 Thyroid crisis or storm
0.000 0.286 0.714
E05.4 Thyrotoxicosis factitia
0.000 0.286 0.714
E05.3 Thyrotoxicosis from ectopic thyroid tissue
0.000 0.286 0.714
E05.1 Thyrotoxicosis with toxic single thyroid nodule
0.000 0.286 0.714
E10.0 With coma
0.000 0.292 0.708
E78.3 Hyperchylomicronaemia
0.000 0.295 0.705
E78.6 Lipoprotein deficiency
0.000 0.295 0.705
E77 Disorders of glycoprotein metabolism
0.000 0.299 0.701
E76 Disorders of glycosaminoglycan metabolism
0.000 0.299 0.701
E72 Other disorders of amino-acid metabolism
0.000 0.299 0.701
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism
0.000 0.299 0.701
E70 Disorders of aromatic amino-acid metabolism
0.000 0.299 0.701
E90 Nutritional and metabolic disorders in diseases classified elsewhere
0.000 0.299 0.701
E40-E46 Malnutrition
0.000 0.299 0.701
E78.5 Hyperlipidaemia, unspecified
0.000 0.300 0.700
E10.1 With ketoacidosis
0.000 0.300 0.700
E83 Disorders of mineral metabolism
0.662 0.307 0.031
E02 Subclinical iodine-deficiency hypothyroidism
0.000 0.311 0.689
E75 Disorders of sphingolipid metabolism and other lipid storage disorders
0.000 0.315 0.684
L40.2 Acrodermatitis continua
0.000 0.316 0.684
E14.4 With neurological complications
0.000 0.320 0.680
L40.4 Guttate psoriasis
0.000 0.322 0.678
E84 Cystic fibrosis
0.000 0.325 0.675
K90.4 Malabsorption due to intolerance, not elsewhere classified
0.000 0.336 0.664
E14.6 With other specified complications
0.000 0.341 0.659
E14.1 With ketoacidosis
0.000 0.343 0.657
E16 Other disorders of pancreatic internal secretion
0.000 0.344 0.656
E14.7 With multiple complications
0.000 0.345 0.655
E14.0 With coma
0.000 0.345 0.655
G37 Other demyelinating diseases of central nervous system
0.653 0.347 0.000
E14.2 Withrenal complications
0.000 0.365 0.635
E80.6 Other disorders of bilirubin metabolism
0.000 0.365 0.635
E03.1 Congenital hypothyroidism without goitre
0.000 0.367 0.633
L40-L45 Papulosquamous disorders
0.000 0.376 0.624
E11.8 With unspecified complications
0.000 0.377 0.623
E80.4 Gilbert's syndrome
0.000 0.379 0.621
E74.3 Other disorders of intestinal carbohydrate absorption
0.000 0.380 0.620
E80.2 Other porphyria
0.000 0.384 0.616
E14.8 With unspecified complications
0.000 0.385 0.615
E10.2 With renal complications
0.000 0.388 0.612
E79.0 Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease
0.000 0.388 0.611
E05.8 Other thyrotoxicosis
0.000 0.393 0.607
K90.9 Intestinal malabsorption, unspecified
0.000 0.395 0.605
E07.1 Dyshormogenetic goitre
0.000 0.396 0.603
E07.0 Hypersecretion of calcitonin
0.000 0.396 0.603
E10.5 With peripheral circulatory complications
0.000 0.398 0.601
C83.3 Large cell (diffuse)
0.000 0.405 0.595
G37.9 Demyelinating disease of central nervous system, unspecified
0.591 0.409 0.000
E83.3 Disorders of phosphorus metabolism
0.581 0.410 0.008
E80.7 Disorder of bilirubin metabolism, unspecified
0.000 0.421 0.579
E80.5 Crigler-Najjar syndrome
0.000 0.421 0.579
E80.3 Defects of catalase and peroxydase
0.000 0.421 0.579
E80.0 Hereditary erythropoietic porphyria
0.000 0.421 0.579
E80.1 Porphyria cutanea tarda
0.000 0.426 0.574
E07.8 Other specified disorders of thyroid
0.000 0.427 0.573
E15 Nondiabetic hypoglycaemic coma
0.000 0.427 0.573
E73 Lactose intolerance
0.000 0.435 0.564
E88 Other metabolic disorders
0.000 0.435 0.564
L40.3 Pustulosis palmaris et plantaris
0.000 0.440 0.560
G36 Other acute disseminated demyelination
0.551 0.449 0.000
E79.9 Disorder of purine and pyrimidine metabolism, unspecified
0.000 0.452 0.548
E79.8 Other disorders of purine and pyrimidine metabolism
0.000 0.452 0.548
E79.1 Lesch-Nyhan syndrome
0.000 0.452 0.548
E13.9 Without complications
0.000 0.456 0.544
L43 Lichen planus
0.000 0.462 0.538
E74.9 Disorder of carbohydrate metabolism, unspecified
0.000 0.463 0.537
E74.8 Other specified disorders of carbohydrate metabolism
0.000 0.463 0.537
E74.4 Disorders of pyruvate metabolism and gluconeogenesis
0.000 0.463 0.537
E74.2 Disorders of galactose metabolism
0.000 0.463 0.537
E74.1 Disorders of fructose metabolism
0.000 0.463 0.537
K90.3 Pancreatic steatorrhoea
0.000 0.465 0.535
K90.2 Blind loop syndrome, not elsewhere classified
0.000 0.465 0.535
K90.1 Tropical sprue
0.000 0.465 0.535
K90.8 Other intestinal malabsorption
0.000 0.466 0.534
E83.9 Disorder of mineral metabolism, unspecified
0.513 0.467 0.020
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified
0.000 0.471 0.529
E16.2 Hypoglycaemia, unspecified
0.000 0.472 0.528
G37.8 Other specified demyelinating diseases of central nervous system
0.527 0.473 0.000
E13.8 With unspecified complications
0.000 0.483 0.517
E13.7 With multiple complications
0.000 0.483 0.517
E13.6 With other specified complications
0.000 0.483 0.517
E13.5 With peripheral circulatory complications
0.000 0.483 0.517
E13.4 With neurological complications
0.000 0.483 0.517
E13.2 With renal complications
0.000 0.483 0.517
E13.1 With ketoacidosis
0.000 0.483 0.517
E13.0 With coma
0.000 0.483 0.517
E12.9 Without complications
0.000 0.486 0.514
E12.8 With unspecified complications
0.000 0.486 0.514
E12.7 With multiple complications
0.000 0.486 0.514
E12.6 With other specified complications
0.000 0.486 0.514
E12.5 With peripheral circulatory complications
0.000 0.486 0.514
E12.4 With neurological complications
0.000 0.486 0.514
E12.3 With ophthalmic complications
0.000 0.486 0.514
E12.2 With renal complications
0.000 0.486 0.514
E12.1 With ketoacidosis
0.000 0.486 0.514
E12.0 With coma
0.000 0.486 0.514
E00.9 Congenital iodine-deficiency syndrome, unspecified
0.000 0.486 0.514
E00.2 Congenital iodine-deficiency syndrome, mixed type
0.000 0.486 0.514
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type
0.000 0.486 0.514
E00.0 Congenital iodine-deficiency syndrome, neurological type
0.000 0.486 0.514
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.486 0.514
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified
0.000 0.486 0.514
E01.1 Iodine-deficiency-related multinodular (endemic) goitre
0.000 0.486 0.514
E01.0 Iodine-deficiency-related diffuse (endemic) goitre
0.000 0.486 0.514
E16.1 Other hypoglycaemia
0.000 0.489 0.511
E11.5 With peripheral circulatory complications
0.000 0.490 0.510
E70.9 Disorder of aromatic amino-acid metabolism, unspecified
0.000 0.497 0.503
E70.8 Other disorders of aromatic amino-acid metabolism
0.000 0.497 0.503
E70.3 Albinism
0.000 0.497 0.503
E70.2 Disorders of tyrosine metabolism
0.000 0.497 0.503
E70.1 Other hyperphenylalaninaemias
0.000 0.497 0.503
E70.0 Classical phenylketonuria
0.000 0.497 0.503
E71.3 Disorders of fatty-acid metabolism
0.000 0.497 0.503
E71.2 Disorder of branched-chain amino-acid metabolism, unspecified
0.000 0.497 0.503
E71.1 Other disorders of branched-chain amino-acid metabolism
0.000 0.497 0.503
E71.0 Maple-syrup-urine disease
0.000 0.497 0.503
E72.9 Disorder of amino-acid metabolism, unspecified
0.000 0.497 0.503
E72.8 Other specified disorders of amino-acid metabolism
0.000 0.497 0.503
E72.5 Disorders of glycine metabolism
0.000 0.497 0.503
E72.4 Disorders of ornithine metabolism
0.000 0.497 0.503
E72.3 Disorders of lysine and hydroxylysine metabolism
0.000 0.497 0.503
E72.2 Disorders of urea cycle metabolism
0.000 0.497 0.503
E72.1 Disorders of sulphur-bearing amino-acid metabolism
0.000 0.497 0.503
E72.0 Disorders of amino-acid transport
0.000 0.497 0.503
E76.9 Disorder of glucosaminoglycan metabolism, unspecified
0.000 0.497 0.503
E76.8 Other disorders of glucosaminoglycan metabolism
0.000 0.497 0.503
E76.3 Mucopolysaccharidosis, unspecified
0.000 0.497 0.503
E76.2 Other mucopolysaccharidoses
0.000 0.497 0.503
E76.1 Mucopolysaccharidosis, type II
0.000 0.497 0.503
E76.0 Mucopolysaccharidosis, type I
0.000 0.497 0.503
E77.9 Disorder of glycoprotein metabolism, unspecified
0.000 0.497 0.503
E77.8 Other disorders of glycoprotein metabolism
0.000 0.497 0.503
E77.1 Defects in glycoprotein degradation
0.000 0.497 0.503
E77.0 Defects in posttranslational modification of lysosomal enzymes
0.000 0.497 0.503
E44 Protein-energy malnutrition of moderate and mild degree
0.000 0.497 0.503
E45 Retarded development following protein-energy malnutrition
0.000 0.497 0.503
E43 Unspecified severe protein-energy malnutrition
0.000 0.497 0.503
E42 Marasmic kwashiorkor
0.000 0.497 0.503
E41 Nutritional marasmus
0.000 0.497 0.503
E40 Kwashiorkor
0.000 0.497 0.503
E10.4 With neurological complications
0.000 0.498 0.501
L43.9 Lichen planus, unspecified
0.000 0.502 0.498
E83.8 Other disorders of mineral metabolism
0.474 0.503 0.023
E83.2 Disorders of zinc metabolism
0.474 0.503 0.023
E83.0 Disorders of copper metabolism
0.474 0.503 0.023
E75.6 Lipid storage disorder, unspecified
0.000 0.509 0.491
E75.4 Neuronal ceroid lipofuscinosis
0.000 0.509 0.491
E75.3 Sphingolipidosis, unspecified
0.000 0.509 0.491
E75.2 Other sphingolipidosis
0.000 0.509 0.491
E75.1 Other gangliosidosis
0.000 0.509 0.491
E75.0 GM2 gangliosidosis
0.000 0.509 0.491
E13.3 With ophthalmic complications
0.000 0.509 0.490
E46 Unspecified protein-energy malnutrition
0.000 0.513 0.487
L42 Pityriasis rosea
0.000 0.514 0.486
E84.8 Cystic fibrosis with other manifestations
0.000 0.516 0.484
E84.1 Cystic fibrosis with intestinal manifestations
0.000 0.516 0.484
E84.0 Cystic fibrosis with pulmonary manifestations
0.000 0.516 0.484
E74.0 Glycogen storage disease
0.000 0.523 0.477
E75.5 Other lipid storage disorders
0.000 0.526 0.474
E16.9 Disorder of pancreatic internal secretion, unspecified
0.000 0.530 0.470
E16.8 Other specified disorders of pancreatic internal secretion
0.000 0.530 0.470
E16.4 Abnormal secretion of gastrin
0.000 0.530 0.470
E16.3 Increased secretion of glucagon
0.000 0.530 0.470
G37.5 Concentric sclerosis [Balo]
0.468 0.532 0.000
G37.4 Subacute necrotising myelitis
0.468 0.532 0.000
G37.2 Central pontine myelinolysis
0.468 0.532 0.000
G37.1 Central demyelination of corpus callosum
0.468 0.532 0.000
G37.0 Diffuse sclerosis
0.468 0.532 0.000
E16.0 Drug-induced hypoglycaemia without coma
0.000 0.536 0.464
E11.6 With other specified complications
0.000 0.538 0.462
E84.9 Cystic fibrosis, unspecified
0.000 0.543 0.457
G37.3 Acute transverse myelitis in demyelinating disease of central nervous system
0.449 0.551 0.000
L44 Other papulosquamous disorders
0.000 0.553 0.447
L41 Parapsoriasis
0.000 0.553 0.447
L45 Papulosquamous disorders in diseases classified elsewhere
0.000 0.553 0.447
E88.2 Lipomatosis, not elsewhere classified
0.000 0.559 0.441
E89.6 Postprocedural adrenocortical(-medullary) hypofunction
0.000 0.567 0.433
G36.0 Neuromyelitis optica [Devic]
0.432 0.568 0.000
E05.2 Thyrotoxicosis with toxic multinodular goitre
0.001 0.569 0.430
E11.4 With neurological complications
0.000 0.570 0.430
E85 Amyloidosis
0.001 0.572 0.427
C83 Diffuse non-Hodgkin's lymphoma
0.005 0.575 0.420
E05.0 Thyrotoxicosis with diffuse goitre
0.000 0.584 0.416
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.001 0.586 0.413
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.006 0.593 0.400
C85.9 Non-Hodgkin's lymphoma, unspecified type
0.000 0.593 0.407
E73.8 Other lactose intolerance
0.000 0.595 0.405
E73.1 Secondary lactase deficiency
0.000 0.595 0.405
E73.0 Congenital lactase deficiency
0.000 0.595 0.405
C85.1 B-cell lymphoma, unspecified
0.000 0.595 0.405
E88.9 Metabolic disorder, unspecified
0.000 0.595 0.405
E88.8 Other specified metabolic disorders
0.000 0.595 0.405
E89.4 Postprocedural ovarian failure
0.000 0.597 0.402
E88.3 Tumour lysis syndrome
0.000 0.600 0.399
G36.9 Acute disseminated demyelination, unspecified
0.395 0.605 0.000
G36.8 Other specified acute disseminated demyelination
0.395 0.605 0.000
G36.1 Acute and subacute haemorrhagic leukoencephalitis [Hurst]
0.395 0.605 0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.002 0.606 0.392
C82.9 Follicular non-Hodgkin's lymphoma, unspecified
0.000 0.611 0.389
L43.3 Subacute (active) lichen planus
0.000 0.614 0.386
L43.2 Lichenoid drug reaction
0.000 0.614 0.386
L43.1 Bullous lichen planus
0.000 0.614 0.386
L43.0 Hypertrophic lichen planus
0.000 0.614 0.386
E06 Thyroiditis
0.000 0.616 0.384
E88.1 Lipodystrophy, not elsewhere classified
0.000 0.617 0.383
E89.9 Postprocedural endocrine and metabolic disorder, unspecified
0.000 0.620 0.379
E89.8 Other postprocedural endocrine and metabolic disorders
0.000 0.620 0.379
E89.5 Postprocedural testicular hypofunction
0.000 0.620 0.379
E89.1 Postprocedural hypoinsulinaemia
0.000 0.620 0.379
E20-E35 Disorders of other endocrine glands
0.000 0.621 0.379
E83.4 Disorders of magnesium metabolism
0.359 0.630 0.011
E89.3 Postprocedural hypopituitarism
0.000 0.638 0.362
E44.1 Mild protein-energy malnutrition
0.000 0.639 0.360
E44.0 Moderate protein-energy malnutrition
0.000 0.639 0.360
E28 Ovarian dysfunction
0.000 0.659 0.341
C83.7 Burkitt's tumour
0.003 0.673 0.324
E65-E68 Obesity and other hyperalimentation
0.000 0.673 0.326
E28.2 Polycystic ovarian syndrome
0.000 0.677 0.323
L41.9 Parapsoriasis, unspecified
0.000 0.679 0.321
L41.8 Other parapsoriasis
0.000 0.679 0.321
L41.5 Retiform parapsoriasis
0.000 0.679 0.321
L41.4 Large plaque parapsoriasis
0.000 0.679 0.321
L41.3 Small plaque parapsoriasis
0.000 0.679 0.321
L41.2 Lymphomatoid papulosis
0.000 0.679 0.321
L41.1 Pityriasis lichenoides chronica
0.000 0.679 0.321
L41.0 Pityriasis lichenoides et varioliformis acuta
0.000 0.679 0.321
L44.9 Papulosquamous disorder, unspecified
0.000 0.679 0.321
L44.8 Other specified papulosquamous disorders
0.000 0.679 0.321
L44.4 Infantile papular acrodermatitis [Giannotti-Crosti]
0.000 0.679 0.321
L44.3 Lichen ruber moniliformis
0.000 0.679 0.321
L44.2 Lichen striatus
0.000 0.679 0.321
L44.1 Lichen nitidus
0.000 0.679 0.321
L44.0 Pityriasis rubra pilaris
0.000 0.679 0.321
E78.9 Disorder of lipoprotein metabolism, unspecified
0.000 0.679 0.320
E89.2 Postprocedural hypoparathyroidism
0.000 0.682 0.318
C82.2 Large cell, follicular
0.001 0.683 0.316
E85.2 Heredofamilial amyloidosis, unspecified
0.001 0.693 0.307
E85.1 Neuropathic heredofamilial amyloidosis
0.001 0.693 0.307
E85.0 Nonneuropathic heredofamilial amyloidosis
0.001 0.693 0.307
L43.8 Other lichen planus
0.000 0.693 0.306
C83.6 Undifferentiated (diffuse)
0.003 0.695 0.301
C83.5 Lymphoblastic (diffuse)
0.003 0.695 0.301
C83.4 Immunoblastic (diffuse)
0.003 0.695 0.301
C83.2 Mixed small and large cell (diffuse)
0.003 0.695 0.301
C82.3 Follicular lymphoma grade IIIa
0.001 0.695 0.303
E24 Cushing's syndrome
0.000 0.696 0.304
E23 Hypofunction and other disorders of pituitary gland
0.000 0.700 0.300
C85.2 Mediastinal (thymic) large B-cell lymphoma
0.001 0.703 0.296
C85.0 Lymphosarcoma
0.001 0.703 0.296
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.000 0.705 0.295
C81 Hodgkin's disease
0.003 0.706 0.291
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified
0.003 0.706 0.290
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.005 0.708 0.287
C86 Other specified types of T/NK-cell lymphoma
0.005 0.708 0.287
E85.8 Other amyloidosis
0.001 0.708 0.291
C84 Peripheral and cutaneous T-cell lymphomas
0.004 0.712 0.284
E85.9 Amyloidosis, unspecified
0.001 0.714 0.286
C85.7 Other specified types of non-Hodgkin's lymphoma
0.001 0.714 0.286
M06.99 Rheumatoid arthritis, unspecified (Site unspecified)
0.000 0.717 0.283
E50-E64 Other nutritional deficiencies
0.000 0.717 0.283
C82.6 Cutaneous follicle centre lymphoma
0.002 0.717 0.281
C82.5 Diffuse follicle centre lymphoma
0.002 0.717 0.281
M06.9 Rheumatoid arthritis, unspecified
0.000 0.718 0.282
C82.7 Other types of follicular non-Hodgkin's lymphoma
0.001 0.719 0.279
E83.5 Disorders of calcium metabolism
0.277 0.720 0.004
E06.5 Other chronic thyroiditis
0.000 0.724 0.275
E06.4 Drug-induced thyroiditis
0.000 0.724 0.275
E06.2 Chronic thyroiditis with transient thyrotoxicosis
0.000 0.724 0.275
E06.0 Acute thyroiditis
0.000 0.724 0.275
E35 Disorders of endocrine glands in diseases classified elsewhere
0.000 0.728 0.272
E32 Diseases of thymus
0.000 0.728 0.272
E31 Polyglandular dysfunction
0.000 0.728 0.272
E30 Disorders of puberty, not elsewhere classified
0.000 0.728 0.272
E25 Adrenogenital disorders
0.000 0.728 0.272
C82.0 Small cleaved cell, follicular
0.001 0.731 0.267
E73.9 Lactose intolerance, unspecified
0.001 0.732 0.268
C94 Other leukaemias of specified cell type
0.005 0.733 0.262
E21.3 Hyperparathyroidism, unspecified
0.000 0.736 0.264
M06.94 Rheumatoid arthritis, unspecified (Hand)
0.000 0.737 0.263
E06.1 Subacute thyroiditis
0.001 0.738 0.262
C82.4 Follicular lymphoma grade IIIb
0.002 0.738 0.260
E26 Hyperaldosteronism
0.000 0.742 0.258
M06.91 Rheumatoid arthritis, unspecified (Shoulder region)
0.000 0.745 0.255
C81.9 Hodgkin's disease, unspecified
0.001 0.751 0.248
C93 Monocytic leukaemia
0.005 0.751 0.243
E85.4 Organ-limited amyloidosis
0.001 0.754 0.246
E28.9 Ovarian dysfunction, unspecified
0.000 0.755 0.244
E28.8 Other ovarian dysfunction
0.000 0.755 0.244
E28.1 Androgen excess
0.000 0.755 0.244
E28.0 Oestrogen excess
0.000 0.755 0.244
E23.7 Disorder of pituitary gland, unspecified
0.000 0.756 0.244
C83.1 Small cleaved cell (diffuse)
0.004 0.757 0.239
E24.2 Drug-induced Cushing's syndrome
0.000 0.757 0.243
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)
0.000 0.759 0.241
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified
0.000 0.761 0.239
M06.96 Rheumatoid arthritis, unspecified (Lower leg)
0.000 0.762 0.238
M06.92 Rheumatoid arthritis, unspecified (Upper arm)
0.000 0.763 0.237
E23.2 Diabetes insipidus
0.000 0.764 0.236
E67 Other hyperalimentation
0.000 0.766 0.234
E68 Sequelae of hyperalimentation
0.000 0.766 0.234
E85.3 Secondary systemic amyloidosis
0.001 0.771 0.229
C88 Malignant immunoproliferative diseases
0.006 0.771 0.223
E24.9 Cushing's syndrome, unspecified
0.000 0.771 0.229
E21.5 Disorder of parathyroid gland, unspecified
0.000 0.776 0.224
M06.95 Rheumatoid arthritis, unspecified (Pelvic region and thigh)
0.000 0.777 0.223
E20 Hypoparathyroidism
0.000 0.777 0.222
C91 Lymphoid leukaemia
0.004 0.781 0.215
E24.8 Other Cushing's syndrome
0.000 0.782 0.218
E24.4 Alcohol-induced pseudo-Cushing's syndrome
0.000 0.782 0.218
E24.3 Ectopic ACTH syndrome
0.000 0.782 0.218
E24.1 Nelson's syndrome
0.000 0.782 0.218
E24.0 Pituitary-dependent Cushing's disease
0.000 0.782 0.218
E21.1 Secondary hyperparathyroidism, not elsewhere classified
0.000 0.784 0.216
E23.3 Hypothalamic dysfunction, not elsewhere classified
0.000 0.785 0.215
E23.1 Drug-induced hypopituitarism
0.000 0.785 0.215
C84.5 Other and unspecified T-cell lymphomas
0.002 0.787 0.211
E21.4 Other specified disorders of parathyroid gland
0.000 0.788 0.211
E21.2 Other hyperparathyroidism
0.000 0.788 0.211
C81.4 Lymphocyte-rich classical Hodgkin lymphoma
0.003 0.789 0.209
C81.3 Lymphocytic depletion
0.003 0.789 0.209
C81.2 Mixed cellularity
0.003 0.789 0.209
M06.93 Rheumatoid arthritis, unspecified (Forearm)
0.000 0.789 0.211
C86.6 Primary cutaneous CD30-positive T-cell proliferations
0.004 0.791 0.206
C86.5 Angioimmunoblastic T-cell lymphoma
0.004 0.791 0.206
C86.4 Blastic NK-cell lymphoma
0.004 0.791 0.206
C86.3 Subcutaneous panniculitis-like T-cell lymphoma
0.004 0.791 0.206
C86.2 Enteropathy-type (intestinal) T-cell lymphoma
0.004 0.791 0.206
C86.1 Hepatosplenic T-cell lymphoma
0.004 0.791 0.206
C86.0 Extranodal NK/T-cell lymphoma, nasal type
0.004 0.791 0.206
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified
0.004 0.791 0.206
C96.8 Histiocytic sarcoma
0.004 0.791 0.206
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.004 0.791 0.206
C96.6 Unifocal Langerhans-cell histiocytosis
0.004 0.791 0.206
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis
0.004 0.791 0.206
C96.4 Sarcoma of dendritic cells (accessory cells)
0.004 0.791 0.206
C96.3 True histiocytic lymphoma
0.004 0.791 0.206
C96.2 Malignant mast cell tumour
0.004 0.791 0.206
C96.1 Malignant histiocytosis
0.004 0.791 0.206
C96.0 Letterer-Siwe disease
0.004 0.791 0.206
C81.7 Other Hodgkin's disease
0.003 0.791 0.206
E29 Testicular dysfunction
0.000 0.792 0.208
E23.6 Other disorders of pituitary gland
0.000 0.792 0.208
C84.9 Mature T/NK-cell lymphoma, unspecified
0.003 0.793 0.204
C84.8 Cutaneous T-cell lymphoma, unspecified
0.003 0.793 0.204
C84.7 Anaplastic large cell lymphoma, ALK-negative
0.003 0.793 0.204
C84.6 Anaplastic large cell lymphoma, ALK-positive
0.003 0.793 0.204
C84.3 Lymphoepithelioid lymphoma
0.003 0.793 0.204
C84.2 T-zone lymphoma
0.003 0.793 0.204
C84.1 Sezary's diease
0.003 0.793 0.204
C84.0 Mycosis fungoides
0.003 0.793 0.204
E64 Sequelae of malnutrition and other nutritional deficiencies
0.000 0.797 0.203
E63 Other nutritional deficiencies
0.000 0.797 0.203
E50 Vitamin A deficiency
0.000 0.797 0.203
E60 Dietary zinc deficiency
0.000 0.797 0.203
E59 Dietary selenium deficiency
0.000 0.797 0.203
E54 Ascorbic acid deficiency
0.000 0.797 0.203
E52 Niacin deficiency [pellagra]
0.000 0.797 0.203
C81.0 Lymphocytic predominance
0.003 0.797 0.200
C82.1 Mixed small cleaved and large cell, follicular
0.002 0.798 0.200
E28.3 Primary ovarian failure
0.000 0.801 0.199
E56 Other vitamin deficiencies
0.000 0.801 0.198
E23.0 Hypopituitarism
0.000 0.804 0.196
E58 Dietary calcium deficiency
0.000 0.804 0.196
E11.3 With ophthalmic complications
0.000 0.804 0.196
E25.9 Adrenogenital disorder, unspecified
0.000 0.805 0.195
E25.8 Other adrenogenital disorders
0.000 0.805 0.195
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency
0.000 0.805 0.195
E30.9 Disorder of puberty, unspecified
0.000 0.805 0.195
E30.8 Other disorders of puberty
0.000 0.805 0.195
E30.1 Precocious puberty
0.000 0.805 0.195
E30.0 Delayed puberty
0.000 0.805 0.195
E31.9 Polyglandular dysfunction, unspecified
0.000 0.805 0.195
E31.8 Other polyglandular dysfunction
0.000 0.805 0.195
E31.1 Polyglandular hyperfunction
0.000 0.805 0.195
E31.0 Autoimmune polyglandular failure
0.000 0.805 0.195
E32.9 Disease of thymus, unspecified
0.000 0.805 0.195
E32.8 Other diseases of thymus
0.000 0.805 0.195
E32.1 Abscess of thymus
0.000 0.805 0.195
E32.0 Persistent hyperplasia of thymus
0.000 0.805 0.195
E35.8 Disorders of other endocrine glands in diseases classified elsewhere
0.000 0.805 0.195
E35.1 Disorders of adrenal glands in diseases classified elsewhere
0.000 0.805 0.195
E35.0 Disorders of thyroid gland in diseases classified elsewhere
0.000 0.805 0.195
C84.4 Peripheral T-cell lymphoma
0.003 0.805 0.192
C95 Leukaemia of unspecified cell type
0.006 0.807 0.187
C91.9 Lymphoid leukaemia, unspecified
0.002 0.807 0.191
M06.98 Rheumatoid arthritis, unspecified (Other)
0.000 0.808 0.192
C94.7 Other specified leukaemias
0.004 0.808 0.188
C94.5 Acute myelofibrosis
0.004 0.808 0.188
C94.4 Acute panmyelosis
0.004 0.808 0.188
C94.3 Mast cell leukaemia
0.004 0.808 0.188
C94.2 Acute megakaryoblastic leukaemia
0.004 0.808 0.188
C94.1 Chronic erythraemia
0.004 0.808 0.188
C94.0 Acute erythraemia and erythroleukaemia
0.004 0.808 0.188
E61 Deficiency of other nutrient elements
0.000 0.810 0.190
E51 Thiamine deficiency
0.000 0.810 0.190
E26.9 Hyperaldosteronism, unspecified
0.000 0.815 0.185
E26.8 Other hyperaldosteronism
0.000 0.815 0.185
E26.1 Secondary hyperaldosteronism
0.000 0.815 0.185
E06.3 Autoimmune thyroiditis
0.000 0.816 0.184
E22 Hyperfunction of pituitary gland
0.000 0.816 0.184
C83.8 Other types of diffuse non-Hodgkin's lymphoma
0.004 0.821 0.175
C93.9 Monocytic leukaemia, unspecified
0.004 0.821 0.174
C93.7 Other monocytic leukaemia
0.004 0.821 0.174
C93.3 Juvenile myelomonocytic leukaemia
0.004 0.821 0.174
C93.2 Subacute monocytic leukaemia
0.004 0.821 0.174
C93.0 Acute monocytic leukaemia
0.004 0.821 0.174
E06.9 Thyroiditis, unspecified
0.001 0.828 0.171
E26.0 Primary hyperaldosteronism
0.000 0.829 0.171
E65 Localised adiposity
0.000 0.830 0.170
E67.8 Other specified hyperalimentation
0.000 0.832 0.168
E67.3 Hypervitaminosis D
0.000 0.832 0.168
E67.2 Megavitamin-B6 syndrome
0.000 0.832 0.168
E67.1 Hypercarotenaemia
0.000 0.832 0.168
E67.0 Hypervitaminosis A
0.000 0.832 0.168
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified
0.004 0.833 0.163
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]
0.004 0.833 0.163
C83.0 Small cell (diffuse)
0.004 0.834 0.162
C88.9 Malignant immunoproliferative disease, unspecified
0.004 0.836 0.160
C88.7 Other malignant immunoproliferative diseases
0.004 0.836 0.160
C88.3 Immunoproliferative small intestinal disease
0.004 0.836 0.160
C88.2 Gamma heavy chain disease
0.004 0.836 0.160
C88.1 Alpha heavy chain disease
0.004 0.836 0.160
C81.1 Nodular sclerosis
0.003 0.839 0.158
E20.8 Other hypoparathyroidism
0.000 0.840 0.159
E20.1 Pseudohypoparathyroidism
0.000 0.840 0.159
E20.0 Idiopathic hypoparathyroidism
0.000 0.840 0.159
C91.5 Adult T-cell leukaemia
0.003 0.842 0.155
C92 Myeloid leukaemia
0.006 0.843 0.152
C91.8 Mature B-cell leukaemia Burkitt-type
0.003 0.843 0.154
C91.7 Other lymphoid leukaemia
0.003 0.843 0.154
C91.6 Prolymphocytic leukaemia of T-cell type
0.003 0.843 0.154
C91.3 Prolymphocytic leukaemia
0.003 0.843 0.154
C91.2 Subacute lymphocytic leukaemia
0.003 0.843 0.154
E89.0 Postprocedural hypothyroidism
0.000 0.848 0.152
E29.9 Testicular dysfunction, unspecified
0.000 0.851 0.149
E29.8 Other testicular dysfunction
0.000 0.851 0.149
E29.0 Testicular hyperfunction
0.000 0.851 0.149
K91.4 Colostomy and enterostomy malfunction
0.146 0.854 0.000
E50.9 Vitamin A deficiency, unspecified
0.000 0.854 0.146
E50.8 Other manifestations of vitamin A deficiency
0.000 0.854 0.146
E50.7 Other ocular manifestations of vitamin A deficiency
0.000 0.854 0.146
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea
0.000 0.854 0.146
E50.5 Vitamin A deficiency with night blindness
0.000 0.854 0.146

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2025 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.